Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Postgraduate Medicine
|
February 9, 2012
Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs
Morgan Bron, Maryna Marynchenko, Hongbo Yang, et al.
Pharmacoeconomics
|
April 22, 2004
Economic implications of treatment-resistant depression among employees
Paul Greenberg, Patricia K Corey-Lisle, Howard Birnbaum, et al.
Current Medical Research and Opinion
|
November 14, 2009
Societal cost of rheumatoid arthritis patients in the US
Howard Birnbaum, Crystal Pike, Rebecca Kaufman, et al.
Psychopharmacology Bulletin
|
November 11, 2003
Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study
Patricia K Corey-Lisle, Howard Birnbaum, Paul Greenberg, et al.
Journal of Occupational and Environmental Medicine
|
May 14, 2005
Employees with overactive bladder: work loss burden
Eric Q Wu, Howard Birnbaum, Maryna Marynchenko, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
November 25, 2003
Attention-deficit/hyperactivity disorder: increased costs for patients and their families
Andrine R Swensen, Howard G Birnbaum, Kristina Secnik, et al.
Chest
|
February 1, 2014
Pulmonary medication adherence and health-care use in cystic fibrosis
Alexandra L Quittner, Jie Zhang, Maryna Marynchenko, et al.
Journal of Medical Economics
|
April 6, 2012
Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients
T Kim Le, Katherine B Winfree, Hongbo Yang, et al.
The Journal of Rheumatology
|
May 17, 2013
Serum urate and incidence of kidney disease among veterans with gout
Eswar Krishnan, Kasem S Akhras, Hari Sharma, et al.
Current Medical Research and Opinion
|
July 16, 2014
Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase
Annie Guérin, Lei Chen, Raluca Ionescu-Ittu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Postgraduate Medicine
|
February 9, 2012
Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs
Morgan Bron, Maryna Marynchenko, Hongbo Yang, et al.
Pharmacoeconomics
|
April 22, 2004
Economic implications of treatment-resistant depression among employees
Paul Greenberg, Patricia K Corey-Lisle, Howard Birnbaum, et al.
Current Medical Research and Opinion
|
November 14, 2009
Societal cost of rheumatoid arthritis patients in the US
Howard Birnbaum, Crystal Pike, Rebecca Kaufman, et al.
Psychopharmacology Bulletin
|
November 11, 2003
Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study
Patricia K Corey-Lisle, Howard Birnbaum, Paul Greenberg, et al.
Journal of Occupational and Environmental Medicine
|
May 14, 2005
Employees with overactive bladder: work loss burden
Eric Q Wu, Howard Birnbaum, Maryna Marynchenko, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
November 25, 2003
Attention-deficit/hyperactivity disorder: increased costs for patients and their families
Andrine R Swensen, Howard G Birnbaum, Kristina Secnik, et al.
Chest
|
February 1, 2014
Pulmonary medication adherence and health-care use in cystic fibrosis
Alexandra L Quittner, Jie Zhang, Maryna Marynchenko, et al.
Journal of Medical Economics
|
April 6, 2012
Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients
T Kim Le, Katherine B Winfree, Hongbo Yang, et al.
The Journal of Rheumatology
|
May 17, 2013
Serum urate and incidence of kidney disease among veterans with gout
Eswar Krishnan, Kasem S Akhras, Hari Sharma, et al.
Current Medical Research and Opinion
|
July 16, 2014
Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase
Annie Guérin, Lei Chen, Raluca Ionescu-Ittu, et al.
Page
of 2